GANX
Gain Therapeutics Inc
1.70$
-1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.0% | -13.0% | +0.3% | +5.1% | -1.6% | -3.0% | +8.1% | +2.2% | +23.8% | -24.6% | +27.5% | – | |
| – | -38.8% | -65.7% | +678.7% | -75.9% | +0.5% | +16.7% | +24.4% | -11.9% | -12.7% | +0.5% | +40.3% | – | |
| – | – | – | +151.8% | -283.5% | – | – | -419.7% | – | – | – | -408.8% | – | |
| – | -97.1% | -84.2% | +718,133.3% | -100.0% | +94,400.0% | -99.7% | -33.3% | +100.0% | -25.0% | +0.0% | +66.7% | – | |
| – | +62.9% | -3.9% | -33.7% | -100.0% | +4,344,600.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1.5% | -2.4% | +9.0% | +3.1% | +0.1% | +2.0% | -0.9% | – | |
| – | +7,009.7% | -101.5% | – | -91.9% | +186.0% | +3.6% | +2.9% | +185.1% | +135.3% | -97.6% | +237.9% | – | |
| – | – | -115.3% | – | -177.6% | – | – | – | – | +469.3% | -135.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.